The Centers for Disease Control and Prevention is facing a leadership shakeup over concerns about vaccine policies and public health. President Trump fired CDC Director Susan Monarez after she refused to resign, leading to the departure of other top officials. Health and Human Services Secretary Robert F. Kennedy Jr., a vaccine skeptic, is making changes to immunization policy, sparking controversy and eroding trust in the agency.

One of the top health officials, Demetre Daskalakis, resigned, citing concerns with CDC policies that he felt were not based on scientific evidence and threatened public health. Kennedy’s actions have led to shifts in Covid vaccine recommendations and FDA approvals, causing stock prices of vaccine makers to dip. The pharmaceutical industry is uncertain about the future of vaccine and public health policy.

As the CDC undergoes leadership changes, there are growing concerns about the agency’s ability to detect and respond to disease outbreaks effectively. Departures of experienced experts could weaken public health efforts and leave the nation vulnerable to infectious diseases. Experts worry that without competent leadership, the CDC’s critical role in protecting public health and preventing disease outbreaks may be compromised.

Read more at CNBC: The vaccine and public health debate explained